Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Microsphere-Based Array for DNA Experiments

By Biotechdaily staff writers
Posted on 24 Jan 2003
New array microspheres used with multiplexing technology are intended to simplify the genotyping assay development process and increase assay flexibility.

These Universal Array microspheres, developed by Tm Bioscience Corp. More...
(Toronto, Canada), are for use on the xMap platform of Luminex Corp. (Austin, TX, USA). In contrast to planar DNA microarray platforms, the Universal Array provides a reproducible, high-throughput and cost-effective means of nucleic acid testing, says Tm Bioscience. No lengthy assay optimization is needed for each new test developed.

Each Universal Array microsphere set carries a unique DNA sequence, thereby providing standardized, stock microspheres. These sequences are rare in any of the currently known genomes, so that the capture conditions are independent of the genetic content being studied. The sequences are intended for multiplexed assays, are optimized for minimum cross-reactivity, and are designed to be an isothermal set. The microspheres may be used in end-user-identified single nucleotide polymorphisms (SNPs) or in predefined kits developed by other Luminex partners.

"The extraordinary accuracy and performance of Tm's Universal Array technology is complemented by the flexibility and cost effectiveness of the Lumenix xMap platform,” said Greg Hines, president of Tm Bioscience.




Related Links:
Lumenix

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.